RSS

Targovax

The first patient has been recruited in an exploratory Phase Ib clinical trial of Targovax’s second product from its RAS-peptide immunotherapy platform, TG02. more

News

Clinical data from the Phase I/II trial of TG01 in resected pancreatic cancer will be presented at the American Society of Clinical Oncology (ASCO) meeting, announces Targovax. more

News